Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...

US FDA accepts Camurus’ resubmission of NDA for Oclaiz for treatment of acromegaly: Lund, Sweden Monday, January 12, 2026, 15:00 Hrs [IST] Camurus, an international, science-led ...

Self-administered injectable contraception has been available in the U.S. for more than two decades, yet a new study found ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...

Intramuscular injection remains a cornerstone of clinical practice, offering rapid drug absorption and efficacy when performed correctly. However, its success is intrinsically linked to precise ...

A study reveals that many clinicians remain unaware of self-administered injectable contraception, despite its decades-long ...

PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a ...

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

This pivotal Phase III trial is designed to evaluate the efficacy and safety of Debio 4126, a novel long-acting octreotide formulation and the first potential 3-month somatostatin analogue (SSA), in ...

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...